US Stock MarketDetailed Quotes

BFRIW BIOFRONTERA INC C/WTS 27/10/2026 (TO PUR COM)

Watchlist
  • 0.068
  • +0.033+92.59%
Close Mar 28 16:00 ET
0Market Cap0.00P/E (TTM)

About BIOFRONTERA INC C/WTS 27/10/2026 (TO PUR COM) Company

Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company is focused on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.

Company Profile

SymbolBFRIW
Company NameBIOFRONTERA INC C/WTS 27/10/2026 (TO PUR COM)
Listing Date10/29/2021
Founded2015
CEODr. Hermann Luebbert, PhD
MarketNASDAQ
Employees85
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address120 Presidnetial Way,Suite 330
CityWoburn
ProvinceMassachusetts
CountryUnited States of America
Zip Code01801
Phone1-781-245-1325

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Hermann Luebbert, PhD
  • Executive Chairman of the Board and Chief Executive Officer
  • 1.28M
  • Eugene Fredrick Leffler, III
  • Chief Financial Officer and Principal Accounting Officer
  • 79.67K
  • Dr. Heikki Lanckriet, PhD
  • Director
  • --
  • John J. Borer, III,J.D.
  • Independent Director
  • 93.55K
  • Kevin D. Weber
  • Independent Director
  • 79.53K
  • Dr. Beth J. Hoffman, PhD
  • Independent Director
  • 93.04K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg